- Rapid-Learning System for Cancer Care
[作者：Abernethy, AP; Etheredge, LM; Ganz, PA; Wallace, P; German, RR; Neti, C; Bach, PB; Murphy, SB,期刊：Journal of clinical oncology, 页码：4268-4274 , 文章类型： Article，,卷期：2010年28-27]
- Compelling public interest is propelling national efforts to advance the evidence base for cancer treatment and control measures and to transform the way in which evidence is aggregated and applied. Substantial investmen...
- Meta-Analysis on the Use of Zidovudine and Interferon-Alfa in Adult T-Cell Leukemia/Lymphoma Showing Improved Survival in the Leukemic Subtypes
[作者：Bazarbachi, A; Plumelle, Y; Ramos, JC; Tortevoye, P; Otrock, Z; Taylor, G; Gessain, A; Harrington, W; Panelatti, G; Hermine, O,期刊：Journal of clinical oncology, 页码：4177-4183 , 文章类型： Article，,卷期：2010年28-27]
- Purpose Human T-cell lymphotropic virus type-I-associated adult T-cell leukemia/lymphoma (ATL) is an aggressive, chemotherapy-resistant malignancy. Multiple small studies using zidovudine (AZT) and interferon-alfa (IFN-a...
- Phase III Trial of Carboplatin Plus Paclitaxel With or Without Gemcitabine in First-Line Treatment of Epithelial Ovarian Cancer
[作者：du Bois, A; Herrstedt, J; Hardy-Bessard, AC; Muller, HH; Harter, P; Kristensen, G; Joly, F; Huober, J; Avall-Lundqvist, E; Weber, B; Kurzeder, C; Jelic, S; Pujade-Lauraine, E; Burges, A; Pfisterer, J; Gropp, M; Staehle, A; Wimberger, P; Jackisch, C; Sehouli, J,期刊：Journal of clinical oncology, 页码：4162-4169 , 文章类型： Article，,卷期：2010年28-27]
- Purpose One attempt to improve long-term survival in patients with advanced ovarian cancer was thought to be the addition of more non-cross-resistant drugs to platinum-paclitaxel combination regimens. Gemcitabine was amo...
- Treatment of Cutaneous Metastases of Merkel Cell Carcinoma With Surface-Mold Computer-Optimized High-Dose-Rate Brachytherapy
[作者：Cotter, SE; Devlin, PM; Sahni, D; Hansen, JL; O'Farrell, DA; Ng, AK; Wang, LC,期刊：Journal of clinical oncology, 页码：E464-E466 , 文章类型： Article，,卷期：2010年28-27]
-
- Role of Cetuximab in the Treatment of Patients With NSCLC: Are We Throwing Out the Baby With the Bath Water?
[作者：Floriani, I; Garassino, MC; Broggini, M; Veronese, S; Marsoni, S; Marabese, M; Farina, G; Scanni, A,期刊：Journal of clinical oncology, 页码：E467-E467 , 文章类型： Letter，,卷期：2010年28-27]
-
- Continental Divide? The Attitudes of US and Canadian Oncologists on the Costs, Cost-Effectiveness, and Health Policies Associated With New Cancer Drugs
[作者：Berry, SR; Bell, CM; Ubel, PA; Evans, WK; Nadler, E; Strevel, EL; Neumann, PJ,期刊：Journal of clinical oncology, 页码：4149-4153 , 文章类型： Proceedings Paper，,卷期：2010年28-27]
- Purpose Oncologists in the United States and Canada work in different health care systems, but physicians in both countries face challenges posed by the rising costs of cancer drugs. We compared their attitudes regarding...
- Salvage Regimens With Autologous Transplantation for Relapsed Large B-Cell Lymphoma in the Rituximab Era
[作者：Gisselbrecht, C; Glass, B; Mounier, N; Gill, DS; Linch, DC; Trneny, M; Bosly, A; Ketterer, N; Shpilberg, O; Hagberg, H; Ma, D; Briere, J; Moskowitz, CH; Schmitz, N,期刊：Journal of clinical oncology, 页码：4184-4190 , 文章类型： Proceedings Paper，,卷期：2010年28-27]
- Purpose Salvage chemotherapy followed by high-dose therapy and autologous stem-cell transplantation (ASCT) is the standard treatment for relapsed diffuse large B-cell lymphoma (DLBCL). Salvage regimens have never been co...
- Vitamin D Insufficiency and Prognosis in Non-Hodgkin's Lymphoma
[作者：Drake, MT; Maurer, MJ; Link, BK; Habermann, TM; Ansell, SM; Micallef, IN; Kelly, JL; Macon, WR; Nowakowski, GS; Inwards, DJ; Johnston, PB; Singh, RJ; Allmer, C; Slager, SL; Weiner, GJ; Witzig, TE; Cerhan, JR,期刊：Journal of clinical oncology, 页码：4191-4198 , 文章类型： Article，,卷期：2010年28-27]
- Purpose Vitamin D insufficiency is common in the United States, with low levels linked in some studies to higher cancer incidence, including non-Hodgkin's lymphoma (NHL). Recent data also suggest that vitamin D insuffici...
- Control of Plasma Uric Acid in Adults at Risk for Tumor Lysis Syndrome: Efficacy and Safety of Rasburicase Alone and Rasburicase Followed by Allopurinol Compared With Allopurinol Alone-Results of a Multicenter Phase III Study
[作者：Cortes, J; Moore, JO; Maziarz, RT; Wetzler, M; Craig, M; Matous, J; Luger, S; Dey, BR; Schiller, GJ; Pham, D; Abboud, CN; Krishnamurthy, M; Brown, A; Laadem, A; Seiter, K,期刊：Journal of clinical oncology, 页码：4207-4213 , 文章类型： Proceedings Paper，,卷期：2010年28-27]
- Purpose Rasburicase is effective in controlling plasma uric acid in pediatric patients with hematologic malignancies. This study in adults evaluated safety of and compared efficacy of rasburicase alone with rasburicase f...
|